Biogen | BIIB - Ebitda



金融业
股票价格
USD 235.34
资产
USD 32.09B
现金及等价物
USD 1.29B
销售成本
USD 945.1M
流动资产
USD 7.31B
流动负债
USD 3.92B
债务
USD 8.09B
EBIT
USD -243.8M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.6
股本和储备
USD 18.85B
销售毛利
USD 2.12B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 7.29B
市值
USD 34.99B
净收入
USD 97.5M
营业费用
USD 2.98B
营业利润
USD -243.8M
普通股股本
USD 146.7M
PE价格收益
23.23
税前利润
USD 647.3M
销售收入
USD 2.74B
销售和管理费用
USD 709.7M
股票
USD 2.38B
贸易债权人
USD 403.9M
应收帐款人
USD 1.79B


Ebitda 更改 日
AbbVie USD 3.69B 1.68B 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Bayer EUR 2.14B 2.31B 2026-06
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Merck USD -1.54B 7.84B 2026-03
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06